Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
LipoKnoxa™ Human PPARA shRNA Ad5 Particle (Silencing)
Cat. No.:
V0126XX83
Species:
Human
Target Gene:
PPARA
Vector System:
Adenovirus
Modulation Type:
Silencing (shRNA)
SPECIFIC INQUIRY
Add to basket
| Sub Cat. No. | TargetSeq | Region | Inquiry |
|---|---|---|---|
| V0126XX83-1 | TGTAGGTAACCGGCATATTAT | 3' UTR | Inquiry |
| V0126XX83-2 | GCGTATGGAAATGGGTTTATA | CDS | Inquiry |
| V0126XX83-3 | GCTTTACGGAATACCAGTATT | CDS | Inquiry |
| V0126XX83-4 | Other | Inquiry |
Product Overview
Description:
LipoKnoxa™ Human PPARA shRNA Ad5 Particle (Silencing) targets PPARA, the master regulator of lipid oxidation and ketogenesis. Knocking down PPARA is vital for exploring hepatic lipid accumulation and metabolic inflexibility during weight gain. All particles are screened through comprehensive QC protocols, ensuring sequence identity and viral activity for optimal experimental reproducibility through our customizable shRNA (U6/miR30) platform.
Production Cell Line:
HEK293
Viral Backbone:
Adenovirus type 5 (dE1/E3)
Promoter:
U6; CMV; EF1α; CAG; UBC
Product Availability:
Produced Upon Order
Specification
Titer Test:
qPCR
Insert Verification:
All viral preparations are validated via Sequencing and PCR to ensure 100% sequence identity and the structural integrity of the vector genomes.
Sterility Test:
This product has been certified sterile following comprehensive microbial growth analysis, confirming the absence of bacterial and fungal contamination.
Mycoplasma Test:
This product was certified negative for mycoplasma contamination following stringent QC analysis, ensuring the absence of all mycoplasmal agents.
Other QC:
Beyond standard protocols, we offer customized knockdown efficiency validation through in vitro and in vivo assessments. This includes precise analysis of mRNA/protein reduction and subsequent biological responses to ensure the functional potency of the shRNA-mediated gene silencing.
Storage:
Upon receipt, viral preparations should be immediately transferred to -80°C for long-term storage to ensure maximum stability and maintain product integrity.
Stability:
This product maintains excellent biological activity for 6–12 months (and up to 2 years in specific cases) when stored continuously at -80°C. Once thawed, the working solution remains stable for 2–3 weeks at 4°C without significant loss of viral potency.
Shipping Condition:
All viral preparations are shipped on dry ice to ensure maximum biological activity and stability during transit.
Handling Notes:
Viral particles are susceptible to temperature fluctuations and freeze-thaw cycles. To preserve functional titers, it is essential to aliquot the vector into low-protein-binding tubes immediately upon first thaw. To ensure experimental success and biological safety, all procedures must be conducted within a certified biosafety cabinet.
Intended Use:
This product is intended for research use only and is not for use in diagnosis or therapeutic applications.
Product Disclaimer:
While our products are committed to excellence through rigorous internal QC inspections, we cannot guarantee specific performance or experimental outcomes due to the inherent complexity of biological systems. Users assume full responsibility for product storage, handling, and strict compliance with all applicable safety protocols, biosafety requirements, and legal regulations during all operational processes.
Target Profile
Gene Name:
PPARA
Full Name:
Peroxisome proliferator activated receptor alpha
Gene Symbol:
PPAR; NR1C1; hPPAR; PPARalpha; PPAR-alpha
Gene ID:
5465
RefSeq ID-1:
NP_001001928.1
RefSeq ID-2:
NM_001001928.4
Summary:
PPARA acts as a major nuclear transcription factor that senses dietary fatty acids. It belongs to the steroid hormone receptor superfamily and is highly expressed in tissues with high fat-burning rates, such as the liver. Upon activation by lipids or hypolipidemic drugs, it stimulates the expression of genes involved in fatty acid oxidation and cholesterol metabolism. This makes PPARA a master regulator of energy mobilization and a key target for treating lipid disorders and obesity-related metabolic diseases.
Related Products
-
LipoKnoxa™ Human FABP1 shRNA Ad5 Particle (Silencing)
-
AdipoUpX™ Human FABP2 Ad5 Particle (Overexpression)
-
AdipoUpX™ Human ATF6 Ad5 Particle (Overexpression)
-
AdipoUpX™ Human SLC2A4 Ad5 Particle (Overexpression)
-
AdipoUpX™ Human PDK4 Ad5 Particle (Overexpression)
-
AdipoUpX™ Human CIDEA Ad5 Particle (Overexpression)